This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Jun 16;334(7606):1233-4.

doi: 10.1136/bmj.39245.502546.BE.

Rosiglitazone and implications for pharmacovigilance

PMID: 17569897
PMCID: PMC1892466
DOI: 10.1136/bmj.39245.502546.BE

Editorial

Rosiglitazone and implications for pharmacovigilance

Dhruv Kazi. BMJ. 2007.

. 2007 Jun 16;334(7606):1233-4.

doi: 10.1136/bmj.39245.502546.BE.

Author

PMID: 17569897
PMCID: PMC1892466
DOI: 10.1136/bmj.39245.502546.BE

Abstract

Postsurveillance data should be systematically collected, timely, and publicly available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

The rosiglitazone story--lessons from an FDA Advisory Committee meeting.
Rosen CJ. Rosen CJ. N Engl J Med. 2007 Aug 30;357(9):844-6. doi: 10.1056/NEJMp078167. Epub 2007 Aug 8. N Engl J Med. 2007. PMID: 17687124 No abstract available.
Rosiglitazone, marketing, and medical science.
Moynihan R. Moynihan R. BMJ. 2010 Apr 7;340:c1848. doi: 10.1136/bmj.c1848. BMJ. 2010. PMID: 20375091 No abstract available.
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
Misbin RI. Misbin RI. Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908. Diabetes Care. 2007. PMID: 18042753 Review. No abstract available.
Revisiting the rosiglitazone story--lessons learned.
Rosen CJ. Rosen CJ. N Engl J Med. 2010 Aug 26;363(9):803-6. doi: 10.1056/NEJMp1008233. Epub 2010 Jul 21. N Engl J Med. 2010. PMID: 20660395 No abstract available.
The rosiglitazone meta-analysis.
McCullough PA, Lepor NE. McCullough PA, et al. Rev Cardiovasc Med. 2007 Spring;8(2):123-6. Rev Cardiovasc Med. 2007. PMID: 17603430 Review. No abstract available.

See all similar articles

Cited by

Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.
Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L. Grosso A, et al. Br J Clin Pharmacol. 2008 Nov;66(5):689-94. doi: 10.1111/j.1365-2125.2008.03273.x. Epub 2008 Jul 31. Br J Clin Pharmacol. 2008. PMID: 18754840 Free PMC article.
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CY. Hsu JC, et al. Clin Ther. 2015 Jul 1;37(7):1420-1432.e1. doi: 10.1016/j.clinthera.2015.04.006. Epub 2015 May 11. Clin Ther. 2015. PMID: 25976425 Free PMC article.
Pharmacovigilance in developing countries.
Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pirmohamed M, et al. BMJ. 2007 Sep 8;335(7618):462. doi: 10.1136/bmj.39323.586123.BE. BMJ. 2007. PMID: 17823149 Free PMC article.
Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.
Hsu JC, Cheng CL, Ross-Degnan D, Wagner AK, Zhang F, Kao Yang YH, Liu LL, Tai HY, Chen KH, Yang PW, Lu CY. Hsu JC, et al. Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1026-35. doi: 10.1002/pds.3834. Epub 2015 Aug 6. Pharmacoepidemiol Drug Saf. 2015. PMID: 26251229 Free PMC article.
Use of the self-controlled case series method in drug safety assessment.
Grosso A, Douglas I, MacAllister R, Petersen I, Smeeth L, Hingorani AD. Grosso A, et al. Expert Opin Drug Saf. 2011 May;10(3):337-40. doi: 10.1517/14740338.2011.562187. Epub 2011 Mar 15. Expert Opin Drug Saf. 2011. PMID: 21406031 Free PMC article. No abstract available.

References

1. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med Published online 21 May 2007 - PubMed
1. National Institute for Health and Clinical Excellence. NICE implementation uptake report: glitazones (rosiglitazone and pioglitazone). 2007. www.nice.org.uk/page.aspx?o=423524
1. Eysenck HJ. Meta-analysis and its problems. BMJ 1994;309:789-92. - PMC - PubMed
1. Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones N, et al. Rosiglitazone evaluated for cardiovascular outcomes—an interim analysis. N Engl J Med Published online 5 June 2007 - PubMed
1. Psaty BM, Furberg CD. The record of rosiglitazone and the risk of myocardial infarction. N Engl J Med Published online 5 June 2007 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information